According to diabetes.org 25.8 million children and adults in the United States—8.3% of the population—have diabetes. Type 2 Diabetes is a lifelong disease that affects the way your body uses food for energy. This disease develops when the cells of the body become resistant to insulin and/or when the pancreas cannot make enough insulin resulting in high blood sugar levels.
Exenatide, also known as Byetta and Bydureon, is a drug meant to treat type 2 diabetes and is administered as a subcutaneous injection given twice daily any time within the 60 minutes before the first and last meal of the day. It belongs to the group of incretin mimetics that means that the drug acts like the natural hormone incretin by:
- encouraging the body to release insulin when your blood sugar level rises
- preventing your pancreas from producing too much glucagon
- slowing down the rate at which your stomach empties after eating
People that used Exenatide to treat type 2 diabetes have reported problems such as acute pancreatitis, impaired kidney dysfunction and thyroid cancer. In August 2008 were reported 4 deaths of Exenatide users from pancreatitis. On March 14, 2013, the U.S. Food and Drug Administration issued an Early Communication Report of possible increased risk of pancreatitis and increased risk of pre-cancerous findings of the pancreas.
If you need legal help, don’t run out of time! Act now! Contact an experienced lawyer and get the best legal help. Come to Legal Bistro!